skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 95  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Role of Nutraceuticals in Statin Intolerant Patients
Material Type:
Article
Add to My Research

The Role of Nutraceuticals in Statin Intolerant Patients

Journal of the American College of Cardiology, 2018-07, Vol.72 (1), p.96-118 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 3, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.04.040 ;PMID: 29957236

Full text available

2
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
Material Type:
Article
Add to My Research

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

The New England journal of medicine, 2017-04, Vol.376 (16), p.1517-1526 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1614062 ;PMID: 28304227

Full text available

3
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
Material Type:
Article
Add to My Research

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)

Pharmaceuticals (Basel, Switzerland), 2023-04, Vol.16 (4), p.577 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph16040577 ;PMID: 37111334

Full text available

4
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
Material Type:
Article
Add to My Research

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4182 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22084182 ;PMID: 33920733

Full text available

5
Genetics of Familial Hypercholesterolemia: New Insights
Material Type:
Article
Add to My Research

Genetics of Familial Hypercholesterolemia: New Insights

Frontiers in genetics, 2020-10, Vol.11, p.574474-574474 [Peer Reviewed Journal]

Copyright © 2020 Vrablik, Tichý, Freiberger, Blaha, Satny and Hubacek. 2020 Vrablik, Tichý, Freiberger, Blaha, Satny and Hubacek ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2020.574474 ;PMID: 33133164

Full text available

6
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters
Material Type:
Article
Add to My Research

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters

Frontiers in genetics, 2022-02, Vol.13, p.849008-849008 [Peer Reviewed Journal]

Copyright © 2022 Todorovova, Altschmiedova, Vrablik and Ceska. ;Copyright © 2022 Todorovova, Altschmiedova, Vrablik and Ceska. 2022 Todorovova, Altschmiedova, Vrablik and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849008 ;PMID: 35295947

Full text available

7
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
Material Type:
Article
Add to My Research

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics

Frontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]

Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707

Full text available

8
Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with Diabetes
Material Type:
Article
Add to My Research

Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with Diabetes

Diagnostics (Basel), 2024-04, Vol.14 (7), p.733 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2075-4418 ;EISSN: 2075-4418 ;DOI: 10.3390/diagnostics14070733 ;PMID: 38611646

Full text available

9
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Material Type:
Article
Add to My Research

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

Pharmacological research, 2023-03, Vol.189, p.106679 [Peer Reviewed Journal]

EISSN: 1096-1186 ;DOI: 10.1016/j.phrs.2023.106679

Digital Resources/Online E-Resources

10
Reduced Introgression of Sex Chromosome Markers in the Mexican Howler Monkey (Alouatta palliata × A. pigra) Hybrid Zone
Material Type:
Article
Add to My Research

Reduced Introgression of Sex Chromosome Markers in the Mexican Howler Monkey (Alouatta palliata × A. pigra) Hybrid Zone

International journal of primatology, 2019-02, Vol.40 (1), p.114-131 [Peer Reviewed Journal]

The Author(s) 2018 ;International Journal of Primatology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0164-0291 ;EISSN: 1573-8604 ;DOI: 10.1007/s10764-018-0056-4 ;PMID: 30880850

Full text available

11
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins
Material Type:
Article
Add to My Research

A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

Journal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284

The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979

Full text available

12
Rare variants in known and novel candidate genes predisposing to statin-associated myopathy
Material Type:
Article
Add to My Research

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy

Pharmacogenomics, 2016-08, Vol.17 (13), p.1405-1414 [Peer Reviewed Journal]

Future Medicine Ltd ;Copyright Future Medicine Ltd Aug 2016 ;ISSN: 1462-2416 ;EISSN: 1744-8042 ;DOI: 10.2217/pgs-2016-0071 ;PMID: 27296017

Full text available

13
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit
Material Type:
Article
Add to My Research

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

International journal of cardiology. Heart & vasculature, 2022-10, Vol.42, p.101117-101117, Article 101117 [Peer Reviewed Journal]

2022 The Authors ;2022 The Authors. ;2022 The Authors. Published by Elsevier B.V. 2022 ;ISSN: 2352-9067 ;EISSN: 2352-9067 ;DOI: 10.1016/j.ijcha.2022.101117 ;PMID: 36118256

Full text available

14
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study
Material Type:
Article
Add to My Research

Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study

Frontiers in medicine, 2022-05, Vol.9, p.861419-861419 [Peer Reviewed Journal]

Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. ;Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2022.861419 ;PMID: 35602501

Full text available

15
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study
Material Type:
Article
Add to My Research

Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]

2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744

Full text available

16
The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals
Material Type:
Article
Add to My Research

The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals

Journal of Obesity, 2013-01, Vol.2013, p.729515-10 [Peer Reviewed Journal]

Copyright © 2013 Eva Tumova et al. ;COPYRIGHT 2014 Hindawi Limited ;Copyright © 2013 Eva Tumova et al. 2013 ;ISSN: 2090-0708 ;EISSN: 2090-0716 ;DOI: 10.1155/2013/729515 ;PMID: 24455214

Full text available

17
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias
Material Type:
Article
Add to My Research

Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias

PloS one, 2023-05, Vol.18 (5), p.e0272883-e0272883 [Peer Reviewed Journal]

Copyright: © 2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Vrablík et al 2023 Vrablík et al ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272883 ;PMID: 37216363

Full text available

18
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Material Type:
Article
Add to My Research

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Nutrition reviews, 2017-09, Vol.75 (9), p.731-767 [Peer Reviewed Journal]

The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1093/nutrit/nux047 ;PMID: 28938795

Full text available

19
Atherosclerosis - so well-known and still mysterious
Material Type:
Article
Add to My Research

Atherosclerosis - so well-known and still mysterious

Physiological research, 2017-01, Vol.66, p.I [Peer Reviewed Journal]

Copyright Institute of Physiology 2017 ;ISSN: 0862-8408 ;EISSN: 1802-9973

Full text available

20
Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
Material Type:
Article
Add to My Research

Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia

Biochemia Medica, 2023-10, Vol.33 (3), p.334-341 [Peer Reviewed Journal]

Croatian Society of Medical Biochemistry and Laboratory Medicine. 2023 Croatian Society of Medical Biochemistry ;ISSN: 1330-0962 ;EISSN: 1846-7482 ;DOI: 10.11613/BM.2023.030705

Full text available

Results 1 - 20 of 95  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (60)

Refine My Results

Creation Date 

From To
  1. Before 2006  (5)
  2. 2006 To 2009  (9)
  3. 2010 To 2013  (10)
  4. 2014 To 2018  (26)
  5. After 2018  (37)
  6. More options open sub menu

Resource Type 

  1. Articles  (69)
  2. Web Resources  (24)
  3. Books  (2)
  4. More options open sub menu

Language 

  1. English  (83)
  2. Czech  (23)
  3. Japanese  (5)
  4. More options open sub menu

Searching Remote Databases, Please Wait